CLL (Chronic Lymphocytic Leukemia),Leukemia Long-Term Efficacy of Venetoclax-Obinutuzumab in CLL Nov 22, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Alliance Phase 3 Study Compares IVO vs Io in Older CLL Patients and Evaluates COVID-19 Impact Nov 20, 2023
CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Rapcabtagene Autoleucel Shows Durable Efficacy And Manageable Safety In R/R DLBCL Patients Nov 08, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Pirtobrutinib Shows Long‑Term Safety In Relapsed/Refractory B‑Cell Malignancies Nov 08, 2023
ALL (Acute Lymphoblastic Leukemia),CLL (Chronic Lymphocytic Leukemia),Leukemia PRIMCAR CD19-CAR T Cells Safety and Remission in R/R B-ALL Patients Oct 12, 2023
ALL (Acute Lymphoblastic Leukemia),CLL (Chronic Lymphocytic Leukemia) Durable Responses in Lymphoma Pts With 4-Gen HUCarT19-IL18 After R/R Anti-CD19 CAR T-Cell Therapy Sep 06, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Ibrutinib-Rituximab and Chemoimmunotherapy Long-term Outcomes in CLL Jun 02, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Phase III Trial of CPX-351 Versus 7+3 Chemo in Elderly AML Patients May 03, 2023
